Takeda Pharmaceutical Company Limited - Strategy and SWOT Report
MarketLine, January 2012, Pages: 58
Takeda Pharmaceutical Company Limited - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.
Features:
- Detailed information on Takeda Pharmaceutical Company Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Takeda Pharmaceutical Company Limited in the form of a SWOT analysis
- An in-depth view of the business model of Takeda Pharmaceutical Company Limited including a breakdown and examination of key business segments
- Intelligence on Takeda Pharmaceutical Company Limited’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Takeda Pharmaceutical Company Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Takeda Pharmaceutical Company (Takeda or ‘the company’) is a global pharmaceutical company based in Japan. It is engaged in the discovery, development, manufacture and marketing of a range of pharmaceutical products including ethical drugs, vaccines, interleukin, over the counter (OTC) drugs, and quasi-drugs. Additionally, the company manufactures and markets other products including chemicals, test reagents and clinical diagnostic products. Takeda markets its products in about 100 countries. It is headquartered in Osaka, Japan and employed 18,498 people as of March 31, 2011. The company recorded revenues of JPY1,419,385 million ($16,606.8 million- ) during the financial year (FY) ended March 2011, a decrease of 3.2% over FY2010. The operating profit of the company was JPY367,084 million ($4,294.9 million- ) during FY2011, a decrease of 12.6% over FY2010. The net profit was JPY247,868 million ($2,900.1 million- ) in FY2011, a decrease of 16.8% over FY2010. - Calculated using the constant conversion rate of JPY1 = $0.0117 for the year ended March 31, 2011.
Reasons to Purchase:
- Gain understanding of Takeda Pharmaceutical Company Limited and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Takeda Pharmaceutical Company Limited as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Takeda Pharmaceutical Company Limited’s business structure, strategy and prospects
Company Snapshot
Takeda Pharmaceutical Company Limited: Company Overview
Takeda Pharmaceutical Company Limited: Overview and Key Facts
Takeda Pharmaceutical Company Limited: Overview
Takeda Pharmaceutical Company Limited: Key Facts
Takeda Pharmaceutical Company Limited: Key Employees
Takeda Pharmaceutical Company Limited: Key Employee Biographies
Takeda Pharmaceutical Company Limited: Major Products and Services
Takeda Pharmaceutical Company Limited: Company History
Takeda Pharmaceutical Company Limited: Management Statement
Takeda Pharmaceutical Company Limited: Locations and Subsidiaries
Takeda Pharmaceutical Company Limited: Key Competitors
Takeda Pharmaceutical Company Limited: Company Analysis
Takeda Pharmaceutical Company Limited: Business Description
Takeda Pharmaceutical Company Limited: SWOT Analysis
Takeda Pharmaceutical Company Limited: SWOT Overview
Takeda Pharmaceutical Company Limited: Strengths
Takeda Pharmaceutical Company Limited: Weaknesses
Takeda Pharmaceutical Company Limited: Opportunities
Takeda Pharmaceutical Company Limited: Threats
Takeda Pharmaceutical Company Limited: Corporate Financial Deals Activity
Takeda Pharmaceutical Company Limited: Financial Deals Overview
Takeda Pharmaceutical Company Limited: Targets and Partners
Takeda Pharmaceutical Company Limited: Top Deals 2007 -YTD-2012
Takeda Pharmaceutical Company Limited: Advisors
Takeda Pharmaceutical Company Limited: Top Legal Advisors
Takeda Pharmaceutical Company Limited: Top Financial Advisors
Takeda Pharmaceutical Company Limited: Mergers and Acquisitions
Takeda Pharmaceutical Company Limited: Corporate Venturing
Takeda Pharmaceutical Company Limited: Partnership
Takeda Pharmaceutical Company Limited: Divestments
Takeda Pharmaceutical Company Limited: Recent Developments
Takeda Pharmaceutical Company Limited: News and Events Summary
Takeda Pharmaceutical Company Limited: Business Expansion
Takeda Pharmaceutical Company Limited: Contracts
Takeda Pharmaceutical Company Limited: Corporate Governance
Takeda Pharmaceutical Company Limited: Financial Deals
Takeda Pharmaceutical Company Limited: Regulatory and Legal Events
Takeda Pharmaceutical Company Limited: Research & Development
Takeda Pharmaceutical Company Limited: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About Datamonitor
List of Tables
Table 1: Takeda Pharmaceutical Company Limited: Key Facts
Table 2: Takeda Pharmaceutical Company Limited: Key Employees
Table 4: Takeda Pharmaceutical Company Limited: Key Competitors
Table 5: Takeda Pharmaceutical Company Limited: Deal Activity by Deal Type - Volume (TTM-)
Table 6: Takeda Pharmaceutical Company Limited: M&A Activity by Geography (TTM-)
Table 7: Takeda Pharmaceutical Company Limited: Deal Activity by Deal Type - Volume (2008 - YTD-2012)
Table 8: Takeda Pharmaceutical Company Limited: M&A Average Deal Size - Value (US$m)
Table 9: Takeda Pharmaceutical Company Limited: Targets and Partners
Table 10: Takeda Pharmaceutical Company Limited: Top Deals 2007 -YTD-2012
Table 11: Takeda Pharmaceutical Company Limited: Legal Advisor Ranking by Value (US$m)
Table 12: Takeda Pharmaceutical Company Limited: Financial Advisor Ranking by Value (US$m)
Table 13: Takeda Pharmaceutical Company Limited: M&A Volume and Value Trend (2008 - YTD-2012)
Table 14: Takeda Pharmaceutical Company Limited: M&A Activity by Geography (2008 - YTD-2012)
Table 15: Takeda Pharmaceutical Company Limited: Corporate Venturing Volume and Value Trend (2008 - YTD-2012)
Table 16: Takeda Pharmaceutical Company Limited: Corporate Venturing by Geography (2008 - YTD-2012)
Table 17: Takeda Pharmaceutical Company Limited: Partnership Volume and Value Trend (2008 - YTD-2012)
Table 18: Takeda Pharmaceutical Company Limited: Partnership Trend by Deal Type (2008 - YTD-2012)
Table 19: Takeda Pharmaceutical Company Limited: Divestments Volume and Value Trend (2008 - YTD-2012)
Table 20: Takeda Pharmaceutical Company Limited: Divestments by Geography (2008 - YTD-2012)
Table 21: Takeda Pharmaceutical Company Limited: News and Events Summary
Table 22: Takeda Pharmaceutical Company Limited: Business Expansion
Table 23: Takeda Pharmaceutical Company Limited: Contracts
Table 24: Takeda Pharmaceutical Company Limited: Corporate Governance
Table 25: Takeda Pharmaceutical Company Limited: Financial Deals
Table 26: Takeda Pharmaceutical Company Limited: Regulatory and Legal Events
Table 27: Takeda Pharmaceutical Company Limited: Research & Development
Table 28: Takeda Pharmaceutical Company Limited: Strategy and Operations
List of Figures
Figure 1: Takeda Pharmaceutical Company Limited: Deal Activity by Deal Type - Volume (TTM-)
Figure 2: Takeda Pharmaceutical Company Limited: M&A Activity by Geography (TTM-)
Figure 3: Takeda Pharmaceutical Company Limited: Deal Activity by Deal Type - Volume (2008 - YTD-2012)
Figure 4: Takeda Pharmaceutical Company Limited: M&A Average Deal Size - Value (US$m)
Figure 5: Takeda Pharmaceutical Company Limited: M&A Volume and Value Trend (2008 - YTD-2012)
Figure 6: Takeda Pharmaceutical Company Limited: M&A Activity by Geography (2008 - YTD-2012)
Figure 7: Takeda Pharmaceutical Company Limited: Corporate Venturing Volume and Value Trend (2008 - YTD-2012)
Figure 8: Takeda Pharmaceutical Company Limited: Corporate Venturing by Geography (2008 - YTD-2012)
Figure 9: Takeda Pharmaceutical Company Limited: Partnership Volume and Value Trend (2008 - YTD-2012)
Figure 10: Takeda Pharmaceutical Company Limited: Partnership Trend by Deal Type (2008 - YTD-2012)
Figure 11: Takeda Pharmaceutical Company Limited: Divestments Volume and Value Trend (2008 - YTD-2012)
Figure 12: Takeda Pharmaceutical Company Limited: Divestments by Geography (2008 - YTD-2012)
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
